Viraj Tyagi
Seminars
Tuesday 6th October 2026
Building High Impact Companion Diagnostics Alliances: Partnering Models that Accelerate Precision Oncology from Development to Delivery
11:10 am
- Exploring Johnson & Johnson’s Pharma–Diagnostics Partnership Model: An overview of how J&J structures and enables early, aligned collaboration between drug and diagnostics teams and external partners to support integrated decision making, development strategies, and regulatory readiness
- Showcasing Insights from Successful Precision Oncology Programs: Learnings drawn from delivering CDx-enabled oncology programs, highlighting the partnership approaches that help translate scientific innovation into meaningful real-world impact
- Looking Ahead – How Precision Medicine Partnerships are Evolving Across the Industry: A broader perspective on where pharma-diagnostics partnering is headed, and key considerations for delivering CDx-enabled therapies at scale across patients, clinicians and health systems
